Moderna's COVID-19 Vaccine Becomes 2nd To Earn FDA Authorization
The Food and Drug Administration greenlights the biotech firm's vaccine for emergency use in the U.S. The move bolsters a vast inoculation effort that's already underway.
Health care workers across the U.S. are getting a new arrow in their quiver.
On Friday, just one week after Pfizer and BioNTech's COVID-19 vaccine received a federal green light, the Food and Drug Administration formally authorized a second vaccine for emergency use — this one developed by Moderna. The won authorization for use in adults following extensive federal analysis of the vaccine, which the FDA found to beat preventing the disease.
